Table 1.
TCE dose
|
TCE dose
|
||||
---|---|---|---|---|---|
Cardiac abnormalitiesa (Dawson et al. 1993) | 1.5 ppm | 1,100 ppm | Heart malformationsb (Johnson et al. 2003) | 1.5 ppm | 1,100 ppm |
L-Transposition (left chest) | 1 | 0 | Abnormal looping | 2 | 0 |
Great vessel defect | 1 | 0 | Aortic hypoplasia | 1 | 0 |
Pulmonary valve defect | 1 | 0 | Pulmonary artery hypoplasia | 1 | 0 |
Atrial septal defect | 4 | 7 | Atrial septal defect | 4 | 7 |
Ventricular septal defects | Ventricular septal defects | ||||
Subaortic | 2 | 1 | Perimembranous (subaortic) | 3 | 3 |
Muscular | 1 | 4 | Muscular | 1 | 1 |
Endocardial cushion defect | 0 | 1 | Atrioventricular septal defect | 0 | 1 |
Aortic valve defect | 0 | 2 | Aortic valve defect | 0 | 2 |
No. with abnormal hearts | 9 | 11 | 9 | 11 | |
No. fetuses examined | 181 | 105 | 181 | 105 |
aData from Dawson et al. (1993) Tables 1 and 3, Groups III and IV.
bData from Johnson et al. (2003) Table 2; percentage was converted to number.